99674170
Feb 27, 2026
Pharmaceutical preparations for neurodegenerative diseases, disorders, and conditions; pharmaceutical preparations for the treatment of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; therapeutic agents for removal of damaged mitochondrial cells for medical purposes; medical diagnostic tests, diagnostic biomarker reagents and assays for detection of Parkinson's Disease, Alzheimer's, ALS, Huntington's, diseases of aging, and other mitochondrial diseases
Pharmaceuticals